Axent Biosciences Revenue

Biotechnology Research • Berkeley, California, United States • 11-20 Employees

Axent Biosciences revenue & valuation

Annual revenue	$1,368,880
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,400,000
Total funding	$100,000

Key Contacts at Axent Biosciences

Abhay Joshi

President & Chief Executive Officer

Hunter Johnson

Co-Founder And Ceo

Riya Muckom

Co-Founder & Consultant

Company overview

Headquarters	130 Stanley Hall, UC Berkeley, Berkeley, California 94720, US
Website	qb3.org
Employees	11-20
Socials

Axent Biosciences Email Formats

Axent Biosciences uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@axentbiosciences.com), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@axentbiosciences.com	100%

About Axent Biosciences

Axent Biosciences develops next generation stem cell therapies to address unmet medical needs in human health. Spun out of Prof. David Schaffer's Lab at UC Berkeley, Axent's platform technologies in stem cell manufacturing and implantation leverage 20+ years of stem cell expertise and 10+ years of biomaterials engineering to overcome major bottlenecks in the clinical development pipeline to efficiently provide high quality stem cell therapeutics to large populations of patients in need.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

C-Suite

Intern

Employees by Department

Axent Biosciences has 8 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Axent Biosciences's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2020-09-18	2	$100,000

Funding Insights

$100,000

Total funding amount

$100,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Axent Biosciences is located in Berkeley, California, US.

Axent Biosciences generates an estimated annual revenue of $1,368,880. This revenue figure reflects the company's market position and business performance in its industry.

Axent Biosciences has an estimated valuation of $4,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Axent Biosciences has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Axent Biosciences has raised a total of $100,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.